Skip to main content
. 2020 Dec 28;11(1):16. doi: 10.3390/jpm11010016

Table 2.

Correlations in Parkinson’s Disease patients, between neuropsychiatric tests scores, dopamine replacement therapy and response inhibition tests scores.

Levodopa eq.
r to z (p level)
M-WCST-sf P
r to z (p level)
SWCT-sv IE-T
r to z (p level)
SWCT-sv IE-E
r to z (p level)
AS tot −0.06 (0.81) 0.14 (0.55) 0.10 (0.68) 0.16 (0.50)
HARS tot −0.52 (0.02) −0.11 (0.64) −0.16 (0.49) 0.06 (0.79)
BDI tot −0.13 (0.58) 0.03 (0.90) −0.04 (0.85) −0.11(0.64)
PPRS tot 0.37 (0.10) 0.04 (0.88) −0.06 (0.80) 0.25 (0.30)

Legend: AS, Apathy Scale; BDI, Beck Depression Inventory; HARS, Hamilton Anxiety Rating Scale; M-WCST-sf, P Modified Wisconsin Card Sorting Test short form perseverative errors; PPRS, Parkinson’s Psychosis Rating Scale; r to z, Fisher’s r to z transformation; SWCT-sv IE-E, Stroop Word-Color Test short form, error interference effect; SWCT-sv IE-T, Stroop Word-Color Test short form, time interference effect. Daily levodopa equivalent doses are expressed as mg/day. Bold values indicate statistically significant differences.